Finland

13.11.04 Turku - Finnish Biotie Therapies Corp. has issued an interim report indicating operating losses from January to September of Euro6.5 million (in January-September 2003: -Euro9.1 million). Cash flow before financing items was... more

Jurilab Teams up With Japanese Summit Pharmaceuticals

09.10.04 Kuopio - Finnish Jurilab Oy has recently established a partnership with Summit Pharmaceuticals International Corporation (SPI), a Japanese company specialized in the support of drug research & development (R&D). Under the... more

Finland

09.10.04 Espoo - The biotech unit of the Finnish research centre VTT and Flanders Interuniversity Institute for Biotechnology (VIB) are developing a metabolic engineering-based method of producing high-value plant secondary compounds -... more

Agreement Worth $13.2 Million

06.08.04 Turku - Biotie Therapies Corp. has recently signed a cooperation and option agreement with Somaxon Pharmaceuticals Inc., San Diego. Under the terms of the agreement Somaxon has an option to an exclusive license for North American... more

Successful Parkinson-Study

10.07.04 Turku - Juvantia Pharma Ltd. presented positive results from a double blind, randomized, placebo controlled phase-2a study on its lead product candidate Fipa-mezole (JP-1730) in late June during the International Congress of... more